After more than a year of conducting clinical research remotely, many sites are finally reopening. However, they’ve also adopted new ways of working that are likely to continue.
Remote monitoring has the potential to offer greater flexibility and convenience while reducing costs in many cases. At the same time, some activities are still better suited for on-site interactions.
In a recent Device Talks Tuesday discussion hosted by Mass Device, IMARC President Brandy Chittester joined three other clinical research leaders to discuss the future of monitoring and some of the challenges of the new hybrid approach.
The group discussed new processes they’ve developed and new technologies they’ve added to support remote trial oversight, how they’re managing safety, quality and compliance, and more.
In case you missed it, you can watch the recording at your convenience.